Randomized Controlled Trial Protocol Comparing Splenic Artery Ligation Versus Octreotide for Portal Flow Modulation (SCALOP) in Living Donor Liver Transplantation
Latest Information Update: 21 May 2025
At a glance
- Drugs Octreotide (Primary)
- Indications Postoperative complications
- Focus Therapeutic Use
- Acronyms SCALOP
Most Recent Events
- 21 May 2025 New trial record